Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.

This double-digit growth in new drug sales showcases the company's ability to successfully commercialize cutting-edge ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

ICER isn't officially involved in the price negotiations introduced under the Inflation Reduction Act (IRA), but contributed a "special report" on Bristol Myers Squibb and Pfizer’s Eliquis ...

Medtronic has been raising its dividend for 47 consecutive years and it offers a high yield now. Bristol Myers Squibb offers ...